Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joan Torras

Showing results (71-80 of 107) with videos related to

Pageof 11
Sort By:
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|September 15, 2012
Impact of small molecules immunosuppressants on P-glycoprotein activity and T-cell functionInés Llaudó, Linda Cassis, Joan Torras, et al.
Kidney International|January 10, 2014
Pharmacokinetic modeling of enterohepatic circulation of mycophenolic acid in renal transplant recipientsHelena Colom, Núria Lloberas, Franc Andreu, et al.
Clinical Kidney Journal|October 6, 2017
Efficacy of mycophenolate treatment in adults with steroid-dependent/frequently relapsing idiopathic nephrotic syndromeDiego Sandoval, Rafael Poveda, Juliana Draibe, et al.
Clinical Pharmacokinetics|May 4, 2023
Comparison of Three Renal Function Formulas for Ganciclovir/Valganciclovir Dose Individualization in CMV-Infected Solid Organ Transplantation Patients Using a Population ApproachPanagiotis Nikolaos Lalagkas, Jorge Iliou, Raul Rigo, et al.
Nefrologia|April 13, 2024
Tools for a personalized tacrolimus dose adjustment in the follow-up of renal transplant recipients. Metabolizing phenotype according to CYP3A genetic polymorphisms versus concentration-dose ratioAnna Vidal-Alabró, Helena Colom, Pere Fontova, et al.
Atencion Primaria|May 19, 2022
[Optimizing blood pressure control through telemedicine in Primary Care in Spain (Iniciativa Óptima): Results from a Delphi study]Carmen Sánchez Peinador, Joan Torras Borrell, María José Castillo Moraga, et al.
Clinical Pharmacokinetics|January 5, 2017
A New CYP3A5*3 and CYP3A4*22 Cluster Influencing Tacrolimus Target Concentrations: A Population ApproachFranc Andreu, Helena Colom, Laure Elens, et al.
International Journal of Molecular Sciences|February 3, 2021
Dual and Opposite Costimulatory Targeting with a Novel Human Fusion Recombinant Protein Effectively Prevents Renal Warm Ischemia Reperfusion Injury and Allograft Rejection in Murine ModelsJordi Guiteras, Laura De Ramon, Elena Crespo, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|May 4, 2018
ANRIL as a genetic marker for cardiovascular events in renal transplant patients - an observational follow-up cohort studyAriadna Arbiol-Roca, Ariadna Padró-Miquel, Anna Vidal-Alabró, et al.
Bio-Protocol|June 21, 2021
<i>In vivo</i> CD40 Silencing by siRNA Infusion in Rodents and Evaluation by Kidney ImmunostainingMiguel Hueso, Adrián Mallén, Elia Ripoll, et al.
Pageof 11

Showing results (71-80 of 107) with videos related to

Sort By:
Pageof 11
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|September 15, 2012
Impact of small molecules immunosuppressants on P-glycoprotein activity and T-cell functionInés Llaudó, Linda Cassis, Joan Torras, et al.
Kidney International|January 10, 2014
Pharmacokinetic modeling of enterohepatic circulation of mycophenolic acid in renal transplant recipientsHelena Colom, Núria Lloberas, Franc Andreu, et al.
Clinical Kidney Journal|October 6, 2017
Efficacy of mycophenolate treatment in adults with steroid-dependent/frequently relapsing idiopathic nephrotic syndromeDiego Sandoval, Rafael Poveda, Juliana Draibe, et al.
Clinical Pharmacokinetics|May 4, 2023
Comparison of Three Renal Function Formulas for Ganciclovir/Valganciclovir Dose Individualization in CMV-Infected Solid Organ Transplantation Patients Using a Population ApproachPanagiotis Nikolaos Lalagkas, Jorge Iliou, Raul Rigo, et al.
Nefrologia|April 13, 2024
Tools for a personalized tacrolimus dose adjustment in the follow-up of renal transplant recipients. Metabolizing phenotype according to CYP3A genetic polymorphisms versus concentration-dose ratioAnna Vidal-Alabró, Helena Colom, Pere Fontova, et al.
Atencion Primaria|May 19, 2022
[Optimizing blood pressure control through telemedicine in Primary Care in Spain (Iniciativa Óptima): Results from a Delphi study]Carmen Sánchez Peinador, Joan Torras Borrell, María José Castillo Moraga, et al.
Clinical Pharmacokinetics|January 5, 2017
A New CYP3A5*3 and CYP3A4*22 Cluster Influencing Tacrolimus Target Concentrations: A Population ApproachFranc Andreu, Helena Colom, Laure Elens, et al.
International Journal of Molecular Sciences|February 3, 2021
Dual and Opposite Costimulatory Targeting with a Novel Human Fusion Recombinant Protein Effectively Prevents Renal Warm Ischemia Reperfusion Injury and Allograft Rejection in Murine ModelsJordi Guiteras, Laura De Ramon, Elena Crespo, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|May 4, 2018
ANRIL as a genetic marker for cardiovascular events in renal transplant patients - an observational follow-up cohort studyAriadna Arbiol-Roca, Ariadna Padró-Miquel, Anna Vidal-Alabró, et al.
Bio-Protocol|June 21, 2021
<i>In vivo</i> CD40 Silencing by siRNA Infusion in Rodents and Evaluation by Kidney ImmunostainingMiguel Hueso, Adrián Mallén, Elia Ripoll, et al.
Pageof 11